Jon Scott Jacobsen
Corporate Officer/Principal chez ACLARIS THERAPEUTICS, INC.
Postes actifs de Jon Scott Jacobsen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Aclaris Life Sciences, Inc.
 Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Corporate Officer/Principal | - | - |
| Directeur Technique/Scientifique/R&D | 26/06/2014 | - |
Historique de carrière de Jon Scott Jacobsen
Anciens postes connus de Jon Scott Jacobsen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Formation de Jon Scott Jacobsen
| Harvey Mudd College | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 3 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Aclaris Life Sciences, Inc.
Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Health Services |
- Bourse
- Insiders
- Jon Scott Jacobsen
- Expérience